PRODUCT SPECIFICATION Strength / Dose: 400 mg/16 mL per vial Dosage Form: Concentrate for intravenous infusion Packing Type: Single-use glass vial, packed in carton Treatment:
Used in the treatment of:
Metastatic colorectal cancer
Lung, kidney, and ovarian cancers
Bevacizumab is a monoclonal antibody that inhibits VEGF, preventing new blood vessel growth required by tumors for survival and metastasis.
Prescription Type: Prescription only (Rx) Generic Name (Drug Name): Bevacizumab Brand: Bryxta 400
Lung, kidney, and ovarian cancers
Bevacizumab is a monoclonal antibody that inhibits VEGF, preventing new blood vessel growth required by tumors for survival and metastasis.
PRODUCT SPECIFICATION
Strength / Dose: 50 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets in blister or bottle, packed in carton
Treatment: Used in the treatment of various malignancies (e.g., lymphomas, leukaemias, solid tumours) and sometimes in non-oncology immunosuppressive settings (as per approved uses)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Cyclophosphamide
Brand: Cycloxan
PRODUCT SPECIFICATION
Strength / Dose: 200 mg per tablet
Dosage Form: Oral tablet
Packing Type: Tablets in blister or bottle, packed in carton
Treatment: Used in the treatment of myelodysplastic syndromes (MDS) and acute myeloid leukaemia (AML) in appropriate patient populations (as per local/regional approval)
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Azacitidine
Brand: Azatend-O
PRODUCT SPECIFICATION
Strength / Dose: 200 mg per vial
Dosage Form: Injection for intravenous use
Packing Type: Glass vial with rubber stopper & aluminium seal, packed in carton
Treatment: Used as a protective agent (uro‐protective) alongside certain chemotherapy agents (for example high-dose cyclophosphamide or ifosfamide) to reduce risk of haemorrhagic cystitis
Prescription Type: Prescription only (Rx)
Generic Name (Drug Name): Mesna
Brand: Mesna 200 mg